Syneron Inc.'s elure(TM) Advanced Dermal Whitening Product Line Wins the Prestigious International Technology Award in the New Technology Launch Category

YOKNEAM, Israel, April 16 /PRNewswire-FirstCall/ -- Syneron Medical Ltd. , an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, won first place in Cosmetics & Toiletries (C&T) magazine's 5th International Technology Award presented at the In-Cosmetic show in Paris, France. This prestigious award recognized the launch of Syneron's elure(TM) Advanced Dermal Whitening product and its significance within the cosmetic R&D industry.

C&T magazine received a record breaking 57 entries in total for the 2010 awards. These entries were judged by a panel of twelve experts in cosmetics R&D to arrive at the six finalists. Syneron's elure was nominated one of the three finalists, and then the winner of the New Technology Launch Category Award for 2010. "We are very pleased with the recognition that RBT and Syneron got by this award," said Dr. Shimon Eckhouse, Chairman of Syneron Medical. "The great work performed by the elure team resulted in this significant achievement, which is part of our long term strategy to offer the most advanced and effective technology to the global aesthetic market."

About Syneron Medical Ltd.

Syneron Medical Ltd. is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets, services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide. Additional information can be found at www.syneron.com and www.candelalaser.com.

CONTACT: Haim Lasser, Chief Executive Officer - RBT, Ltd.,
+972-4-959-0770; or Fabian Tenenbaum, Chief Financial Officer - Syneron
Medical, Ltd., +1-508-358-7400

Web site: http://www.syneron.com/

MORE ON THIS TOPIC